IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$3.04
-0.19 (-5.88%)
Open$3.20
Previous Close$3.23
Day High$3.25
Day Low$3.02
52W High$5.78
52W Low$0.53
Volume—
Avg Volume4.54M
Market Cap570.70M
P/E Ratio23.76
EPS$0.11
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+1,600.7% upside
Current
$3.04
$3.04
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 252.93M | 282.04M | 73.58M |
| Net Income | 20.52M | 20.59M | 12.49M |
| Profit Margin | 8.1% | 7.7% | 17.0% |
| EBITDA | 85.90M | 90.99M | 23.02M |
| Free Cash Flow | — | — | 13.98M |
| Rev Growth | -10.3% | -10.3% | +11.9% |
| Debt/Equity | 0.61 | 0.61 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |